Given the long-term importance of PD-L1 and CSF1R expression to the management of macrophages and inflammation, it seems reasonable to speculate that the observed changes may reflect prophylactic probiotic protection from future risk of IBD. The gene discussed is CSF1R; the disease is inflammatory bowel disease.